CAMBRIDGE, Mass., March 11, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, celebrates World Kidney Day and National Kidney Month with
the launch of new initiatives to increase awareness of chronic
kidney disease (CKD). As reported by the Centers for Disease
Control and Prevention, an estimated 37 million adults in the U.S.
are affected by CKD, a progressive, irreversible, and often
life-altering, illness.
Akebia's campaign aims to engage patients, kidney care
professionals, the kidney community and employees with the goal of
promoting kidney health, honoring kidney patients and applauding
those who care for them. To publicly commemorate the month and
support the kidney community, Akebia's website features a green
National Kidney Month banner and ribbon. Akebia employees are
showing their support with customized green ribbon Zoom backgrounds
for the month. In addition, Akebia's homepage features interviews
with kidney care leaders who discuss the value of increasing
attention on kidney disease. Visit www.akebia.com/kidney-disease/
to view a video.
In conjunction with patient advocacy groups, Akebia is
recognizing those who work tirelessly to help kidney patients. In
the local community, Akebia is a platinum sponsor of the NKF Honors
Gala 2021, an event presented by the National Kidney Foundation
serving New England. The Honors Gala, which takes place virtually
on Saturday, March 20, recognizes
those who have been outstanding in the promotion of kidney health
and the fight against kidney disease. In addition, as part of the
Company's speaker series, Akebia will host Lori Hartwell, Founder of Renal Support Network,
to speak with employees about her experience living with kidney
disease.
"We celebrate National Kidney Month and World Kidney Day to
spotlight the importance of kidney health, increase awareness of
the disease and thank the healthcare professionals and caregivers
who share in our commitment to all patients," said John P. Butler, Chief Executive Officer of
Akebia. "We are inspired by patients who face a life-changing
diagnosis with the belief that life can be better. Their stories
and strength motivate our efforts as we do our part to improve the
standard of care for kidney patients. We remain committed to
bringing innovation to the kidney community."
Through its social media channels, Akebia is highlighting
patient stories and sharing appreciation for the countless
healthcare professionals and caregivers who are dedicated to people
living with kidney disease. Akebia encourages patients, caregivers
and others to unite, spread the word and capture their support
using the hashtags: #NationalKidneyMonth and #WorldKidneyDay.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. The Company
was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Investor Contact
Kristen K. Sheppard, Esq.
Ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-celebrates-world-kidney-day-and-national-kidney-month-301245166.html
SOURCE Akebia Therapeutics